Citation: F. Kanzawa et N. Saijo, IN-VITRO INTERACTION BETWEEN GEMCITABINE AND OTHER ANTICANCER DRUGS USING A NOVEL 3-DIMENSIONAL MODEL, Seminars in oncology, 24(2), 1997, pp. 8-16
Authors:
KANZAWA F
NISHIO K
FUKUOKA K
FUKUDA M
KUNIMOTO T
SAIJO N
Citation: F. Kanzawa et al., EVALUATION OF SYNERGISM BY A NOVEL 3-DIMENSIONAL MODEL FOR THE COMBINED ACTION OF CISPLATIN AND ETOPOSIDE ON THE GROWTH OF A HUMAN SMALL-CELL LUNG-CANCER CELL-LINE, SBC-3, International journal of cancer, 71(3), 1997, pp. 311-319
Authors:
KANZAWA F
NISHIO K
ISHIDA T
FUKUDA M
KUROKAWA H
FUKUMOTO H
NOMOTO Y
FUKUOKA K
BOJANOWSKI K
SAIJO N
Citation: F. Kanzawa et al., ANTITUMOR ACTIVITIES OF A NEW BENZO[C]PHENANTHRIDINE AGENT, METHYL-7-HYDROXY-8-METHOXYBENZO[C]PHENANTHRIDINIUM HYDROGENSULFATE DIHYDRATE (NK109), AGAINST SEVERAL DRUG-RESISTANT HUMAN TUMOR-CELL LINES, British Journal of Cancer, 76(5), 1997, pp. 571-581
Authors:
FUKUDA M
INOMATA M
NISHIO K
FUKUOKA K
KANZAWA F
ARIOKA H
ISHIDA T
FUKUMOTO H
KUROKAWA H
OKA M
SAIJO N
Citation: M. Fukuda et al., A TOPOISOMERASE-II INHIBITOR, NK109, INDUCES DNA SINGLE-STRAND AND DOUBLE-STRAND BREAKS AND APOPTOSIS, Japanese journal of cancer research, 87(10), 1996, pp. 1086-1091
Authors:
OHIRA T
NISHIO K
KANZAWA F
ISHIDA T
OHE Y
ARIOKA H
FUNAYAMA Y
OGASAWARA H
KATO H
SAIJO N
Citation: T. Ohira et al., HYPERSENSITIVITY OF NIH3T3 CELLS TRANSFORMED BY H-RAS GENE TO DNA-TOPOISOMERASE-I INHIBITORS, International journal of cancer, 67(5), 1996, pp. 702-708
Authors:
FUKUDA M
NISHIO K
KANZAWA F
OGASAWARA H
ISHIDA T
ARIOKA H
BOJANOWSKI K
OKA M
SAIJO N
Citation: M. Fukuda et al., SYNERGISM BETWEEN CISPLATIN AND TOPOISOMERASE-I INHIBITORS, NB-506 AND SN-38, IN HUMAN SMALL-CELL LUNG-CANCER CELLS, Cancer research, 56(4), 1996, pp. 789-793
Authors:
OGASAWARA H
NISHIO K
KANZAWA F
LEE YS
FUNAYAMA Y
OHIRA T
KURAISHI Y
ISOGAI Y
SAIJO N
Citation: H. Ogasawara et al., INTRACELLULAR CARBOXYL ESTERASE-ACTIVITY IS A DETERMINANT OF CELLULAR-SENSITIVITY TO THE ANTINEOPLASTIC AGENT KW-2189 IN CELL-LINES RESISTANT TO CISPLATIN AND CPT-11, Japanese journal of cancer research, 86(1), 1995, pp. 124-129
Authors:
FUKUDA M
OHE Y
KANZAWA F
OKA M
HARA K
SAIJO N
Citation: M. Fukuda et al., EVALUATION OF NOVEL PLATINUM COMPLEXES, INHIBITORS OF TOPOISOMERASE-IAND TOPOISOMERASE-II IN NONSMALL CELL LUNG-CANCER (NSCLC) SUBLINES RESISTANT TO CISPLATIN, Anticancer research, 15(2), 1995, pp. 393-398
Citation: F. Kanzawa et al., ANTITUMOR ACTIVITIES OF A NEW INDOLOCARBAZOLE SUBSTANCE, NB-506, AND ESTABLISHMENT OF NB-506-RESISTANT CELL-LINES, SBC-3 NB/, Cancer research, 55(13), 1995, pp. 2806-2813
Authors:
KONDO H
KANZAWA F
NISHIO K
SAITO S
SAIJO N
Citation: H. Kondo et al., IN-VITRO AND IN-VIVO EFFECTS OF CISPLATIN AND ETOPOSIDE IN COMBINATION ON SMALL-CELL LUNG-CANCER CELL-LINES, Japanese journal of cancer research, 85(10), 1994, pp. 1050-1056
Authors:
SAIJO N
NISHIO K
KUBOTA N
KANZAWA F
SHINKAI T
KARATO A
SASAKI Y
EGUCHI K
TAMURA T
OHE Y
OSHITA F
NISHIO M
Citation: N. Saijo et al., 7-ETHYL-10-[4-(1-PIPERIDINO)-1-PIPERIDINO] CARBONYLOXY CAMPTOTHECIN -MECHANISM OF RESISTANCE AND CLINICAL-TRIALS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000112-190000117